Cholinergic deficits are prominent in patients who have dementia associated with Parkinson's disease. We investigated the effects of the dual cholinesterase inhibitor rivastigmine in such patients.

Rivastigmine is a drug that may help people with Alzheimer’s disease improve thinking, memory, communication, and how they perform activities. It is a daily patch people wear on the skin. Alzheimer‘s ...

Nov. 22, 2002 — Rivastigmine (Exelon), which was developed for treatment of Alzheimer's disease, also is beneficial in subcortical vascular dementia, according to results of an open-label study ...

SAN DIEGO — Treatment with rivastigmine (Exelon, Novartis) improves gait variability of patients with Parkinson's disease (PD) without dementia during normal walking and performance of a simple ...

Learn everything you need to know about Rivastigmine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

This medication is a reversible non-competitive inhibitor of acetylcholinestrace, prescribed for mild to moderate dementia in patients with Alzheimer's or Parkinson's disease. Vascular dementia is the ...

Princeton, New Jersey; July 1, 2010 -- Sandoz today announced the introduction of rivastigmine tartrate capsules, an authorized generic equivalent of the Novartis treatment Exelon® capsules, in the US ...

TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the ...

Of particular clinical interest, considering that the only successful pharmacological treatment of cognitive impairment of AD to date has been the cholinesterase inhibitors, may be the reported ...

Please provide your email address to receive an email when new articles are posted on . A study of more than 1,000 patients with Parkinson’s disease dementia found that patients who also had ...

Donepezil (Aricept, Eisai/Pfizer) is an AChE inhibitor, which works by increasing the concentration of acetylcholine at sites of neurotransmission. Donepezil has a marketing authorisation in the UK ...